Task: Answer the multiple choice question.
Query: Which compound exhibits a 17.533% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] CN(C(=O)CCNC(=O)Cn1ccc2ccccc2c1=O)c1ccc(Br)cc1
[b] COc1ccc(OCc2n[nH]c(=S)n2-c2ccc(C)cc2)cc1
Answer: a. CN(C(=O)CCNC(=O)Cn1ccc2ccccc2c1=O)c1ccc(Br)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(C(=O)CCNC(=O)Cn1ccc2ccccc2c1=O)c1ccc(Br)cc1
CN(C(=O)CCNC(=O)Cn1ccc2ccccc2c1=O)c1ccc(Br)cc1
N-(4-bromophenyl)-N-methyl-3-[[2-(1-oxoisoquinolin-2-yl)acetyl]amino]propanamide